ARYL HYDROCARBON RECEPTOR MEDIATES SMOKING-INDUCED RHEUMATOID ARTHRITIS EXACERBATION

Jhimmy Talbot,Raphael Shances Peres,Renê Donizeti Ribeiro de Oliveira,Lidiane de Castro Pinto,Bernhard Ryffel,Thiago M. Cunha,J.C. Alves,Eddy Y Liew,Paulo Louzada‐Júnior,Fernando Q. Cunha
2011-01-01
Abstract:Introduction: Rheumatoid Arthritis (RA) is a multifactorial autoimmune arthropaty with unknown etiology that affects ~1% of worldwide adult population. RA is characterized by joint pain, intense immune cells infiltration in articular tissue, synovial hyperplasy (pannus) and bone destruction. Genetic and environmental factors are associated with RA development, but the interaction of these factors is not well understood. Genetic polymorphisms that can influence the susceptibility to environmental factors may be crucial in RA development. Among the environmental factors, cigarette smoking is the most studied and has been associated with increased susceptibility to RA. However, the mechanisms by which smoking aggravates RA remain unknown. Results: Using a sex/smoking pared samples of Rheumatoid Arthritis Patients and Healthy controls we found an Aryl hydrocarbon receptor (AHR, a key receptor for environmental pollutants) haplotype over-represented in RA patients. This haplotype contains an AHR single nucleotide polymorphism (SNP; rs2066853, allele A) that enhances AHR transactivation function and was related to higher Th17 frequencies in RA. Furthermore, smokers with this AHR haplotype are highly prone to develop RA than non-smokers or smokers without this haplotype. In experimental arthritis, AHR agonists exacerbated antigen-induced arthritis (AIA) in mice, whereas mice genetically deficient in Ahr develop a less severe form of AIA. Furthermore, smoking aggravated AIA in mice in an AHR-dependent manner. Conclusion: These data demonstrate that genetic polymorphisms at AHR are closely linked to smoking-induced RA aggravation, and that individuals with this genotype should be strongly warned against smoking. Financial support: FAPESP (2011/02505-7) and TIMER (HEALTH-F4-
What problem does this paper attempt to address?